Literature DB >> 17118811

Anabolic steroid use in high school students.

Ståle Pallesen1, Ola Jøsendal, Bjørn-Helge Johnsen, Svein Larsen, Helge Molde.   

Abstract

A total of 1351 high school students (52.3% males, 47.7% females) with mean age 17.5 years (SD = 2.2) from randomized school classes in Hordaland County, Norway, participated in an Internet survey conducted in 2004 about the lifetime use of anabolic steroids and personal acquaintance with at least one user of anabolic steroids. In addition to questions about anabolic steroids the participants completed the Hospital Anxiety and Depression Scale and the Alcohol Use Disorders Identification Test. They also answered questions about demography, smoking, and narcotic use. The lifetime prevalence for use of anabolic steroids was 3.6% for males and 0.6% for females. In all, 27.9% of the respondents reported having at least one acquaintance that used or had used anabolic steroids. Use of anabolic steroids and having acquaintances using such drugs were strongly related to use of other drugs such as alcohol, nicotine, and narcotics. Implications for prevention are discussed and the study's limitations are noted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17118811     DOI: 10.1080/10826080601006367

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  18 in total

1.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

2.  Culture, psychosomatics and substance abuse: the example of body image drugs.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Psychother Psychosom       Date:  2012-01-18       Impact factor: 17.659

3.  Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2009-04-01       Impact factor: 4.492

Review 4.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

Review 5.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

6.  Serotonin modulates anxiety-like behaviors during withdrawal from adolescent anabolic-androgenic steroid exposure in Syrian hamsters.

Authors:  Lesley A Ricci; Thomas R Morrison; Richard H Melloni
Journal:  Horm Behav       Date:  2012-09-28       Impact factor: 3.587

Review 7.  The use of anabolic androgenic steroids and polypharmacy: a review of the literature.

Authors:  Tonya Dodge; Margaux F Hoagland
Journal:  Drug Alcohol Depend       Date:  2011-01-12       Impact factor: 4.492

8.  A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity.

Authors:  Harrison G Pope; Joseph Kean; Adam Nash; Gen Kanayama; Douglas B Samuel; Warren K Bickel; James I Hudson
Journal:  Exp Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.157

Review 9.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

Review 10.  Anabolic-androgenic steroid dependence: an emerging disorder.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Addiction       Date:  2009-12       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.